Trial Profile
A phase II/III trial of TW 001 in patients with amyotrophic lateral sclerosis
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Edaravone (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Registrational; Therapeutic Use
- Sponsors Treeway
- 15 Dec 2015 New trial record